Mark E. Hensley

Insider Reports History

Entity
Individual
Location
C/O Heron Therapeutics, Inc., 100 Regency Forest Drive, Suite 300, Cary, NC
Signature
/s/Kathryn Lester Attorney-in-fact for Mark E. Hensley
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark E. Hensley:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HERON THERAPEUTICS, INC. /DE/ Chief Operating Officer Employee Performance Stock Option (Right to Buy) 900K $1.98M $2.20 Apr 28, 2025 Direct
HERON THERAPEUTICS, INC. /DE/ Chief Operating Officer Employee Stock Option (Right to Buy) 500K $1.1M $2.20 Apr 28, 2025 Direct
HERON THERAPEUTICS, INC. /DE/ Chief Operating Officer Restricted Stock Units 500K May 6, 2025 Direct

Insider Reports Filed by Mark E. Hensley

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HRTX HERON THERAPEUTICS, INC. /DE/ May 6, 2025 1 $0 4 May 7, 2025 Chief Operating Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Apr 28, 2025 0 $0 4 Apr 29, 2025 Chief Operating Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Apr 28, 2025 0 $0 3 Apr 29, 2025 Chief Operating Officer